amfAR, The Foundation for AIDS Research

Collaborating for a Cure 

arche logo3

Launched in 2010, the amfAR Research Consortium on HIV Eradication, or ARCHE, supports collaborative teams of scientists in the U.S. and around the world working on a range of HIV cure strategies. To date, amfAR has awarded 53 ARCHE grants, totaling close to $15 million.

“amfAR’s ARCHE program is continuing its tradition of pinpointing the important outstanding questions in research and targeting funding to those researchers who can answer them, wherever they are in the world,” says Dr. Rowena Johnston, amfAR’s vice president and director of research. “We are tremendously excited by the findings these grants could yield and confident they will open a number of new pathways to a cure.”

 
Scully Photo 1

This  project  is  a  clear  example  of  the  power  of  the  ARCHE  mechanism
  of  funding  to  initiate,  maintain  and  extend collaborations,
and rapidly move research questions forward
.”
– Dr. Eileen Scully, Johns Hopkins University
School of Medicine, ARCHE grantee

ARCHE Grantees

2019:
New amfAR Grants Advance HIV Cure and Post-Treatment Control Studies

2018:
amfAR Awards New Funding for Gene Therapy Study Aimed at Curing HIV

2017:
New amfAR Research Grants Advance Gene Therapy and Other Innovative Approaches to HIV Cure

2016:
New amfAR Grant Addresses Key Challenge in Cure Research

2015:
New amfAR Awards Accelerate Research Towards HIV Cure

2014:
Pursuit of HIV Cure Gets Funding Boost from amfAR

HIV Cure Research Gains Momentum from New amfAR Funding

2013:
Infusion of Funding for amfAR HIV Cure Consortium

2012:
Entering Third Year, amfAR Consortium Gathers Momentum in Quest for HIV/AIDS Cure

amfAR Announces Second Round of Cure-Focused Research Grants in Third Year

2011:
amfAR Consortium Helps Lead Efforts for HIV/AIDS Cure

2010:
ARCHE Research Teams and Their Projects

  ARCHE Group 2
ARCHE grantees meet at the amfAR office to discuss their research.  

ARCHE News and Features 

Using Groundbreaking CAR-T Cancer Therapy to Eliminate HIV

A Gene Therapy Revolution?

Stabilize or Stimulate? A New Approach to Attacking the HIV Reservoir

One Cure May Not Fit All

Harnessing the Power of Antibodies
 

Boosting Killer T cells to Eliminate HIV Reservoirs

Sizing Up the HIV Reservoir

Surprising New Development in "Mississippi Child" Case

Testing “Shock and Kill”

New Clues to the Nature of HIV Reservoirs

Working Towards a Cure

Researcher Reports Two HIV Patients Showing No Signs of Virus in Wake of Stem-Cell Transplants

Perfecting Tools to Monitor HIV Viral Loads

Keeping Track of HIV Reservoirs

Research Support from amfAR Documents First Case of Child Cured of HIV

amfAR Awards Three New ARCHE Grants for Cure Research

A Cure for HIV/AIDS: Recent Breakthroughs and New Research Frontiers

Defining HIV Reservoirs

Leading the Charge in Cure Research

HIV in the Crosshairs

Destroying HIV Reservoirs

As Cure Search Intensifies, Questions Arise

Gene Therapy and the Potential for an HIV Cure

amfAR Symposium Looks to Holy Grail of AIDS Research 

amfAR Ramps Up Investment in HIV Cure Research 

ARCHE Researchers Prove the Value of Collaboration 

The Search for a Cure—Why Now? 

Charting a Path to a Cure 

amfAR Consortium To Speed Search for HIV/AIDS Cure 

The Search for a Cure: An Enduring Commitment 

amfAR Launches Cure Consortium